Last reviewed · How we verify
Premenstrual dysphoric disorder
Approved treatments
- Estrace · Pfizer
Estrace works by binding to estrogen receptors in the body, mimicking the effects of natural estrogen. - Ortho-Novum 10/11-21 · Merck & Co.
- Estring · Pfizer Inc.
Prevents pregnancy primarily by suppressing ovulation. - Sertralin · Poznan University of Medical Sciences
- Prozac · RenJi Hospital
- Slynd · Exeltis Usa Inc
Slynd works by binding to the mineralocorticoid receptor, a protein that plays a role in hormone regulation. - Zoloft · Pfizer Inc.
Selective serotonin reuptake inhibitor (SSRI) that blocks the serotonin transporter, increasing synaptic serotonin to improve mood and reduce anxiety. - Prozac · Eli Lilly and Company
Fluoxetine inhibits CNS neuronal uptake of serotonin, though exact mechanism unknown. - Metafolin · University of California, San Diego
Clinical guidelines
- FDA label — 1L
Fluoxetine is indicated for the treatment of Premenstrual Dysphoric Disorder (PMDD).
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Premenstrual dysphoric disorder patent landscape — cliff calendar, originator estates, attackable patents
- Premenstrual dysphoric disorder treatment landscape brief
- Premenstrual dysphoric disorder treatment updates RSS
Frequently asked questions about Premenstrual dysphoric disorder
What drugs treat Premenstrual dysphoric disorder?
Tracked treatments include Estrace, Ortho-Novum 10/11-21, Estring, Sertralin, Prozac, Slynd, Zoloft, Metafolin.
What is the treatment for Premenstrual dysphoric disorder?
Standard treatment for Premenstrual dysphoric disorder includes Estrace, Ortho-Novum 10/11-21, Estring, Sertralin, Prozac. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Premenstrual dysphoric disorder?
FDA label publishes guidelines for Premenstrual dysphoric disorder. 1 guideline references tracked.
Related
- Treatment landscape: Premenstrual dysphoric disorder patent cliff · Premenstrual dysphoric disorder CI report
- Treatment: Estrace · Pfizer
- Treatment: Ortho-Novum 10/11-21 · Merck & Co.
- Treatment: Estring · Pfizer Inc.
- Treatment: Sertralin · Poznan University of Medical Sciences
- Treatment: Prozac · RenJi Hospital
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing